J05AF11 telbivudine
ATC group of level 5 – chemical substance · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 1 medicine in this group.
- 1 no longer supplied or not available
Active substance: Telbivudine – all medicines with this substance, also in combinations.
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AF11 telbivudine 1 medicine
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Sebivo SPC no longer supplied | – |
Other groups of the same level
- J05AF01 zidovudine 6 medicines
- J05AF04 stavudine 1 medicine
- J05AF05 lamivudine 16 medicines
- J05AF06 abacavir 6 medicines
- J05AF07 tenofovir disoproxil 21 medicines
- J05AF08 adefovir dipivoxil 2 medicines
- J05AF09 emtricitabine 2 medicines
- J05AF10 entecavir 26 medicines
Other names of the ATC group
- French: J05AF11 telbivudine
- German: J05AF11 Telbivudin
- German: J05AF11 Telbivudin
- Italian: J05AF11 TELBIVUDINA
- Polish: J05AF11 TELBIVUDIN
- Turkish: J05AF11 telbivudin
- Portuguese (Brazil): J05AF11 Telbivudina
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AF11
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
